Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02354586
Title A Study of Niraparib in Patients With Ovarian Cancer Who Have Received at Least Three Previous Chemotherapy Regimens
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

peritoneal serous adenocarcinoma

fallopian tube serous adenocarcinoma

ovary serous adenocarcinoma

Therapies

Niraparib

Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Chandler Arizona 85224 United States Details
GSK Investigational Site Phoenix Arizona 85016 United States Details
GSK Investigational Site Tucson Arizona 85710 United States Details
GSK Investigational Site Burbank California 91505 United States Details
GSK Investigational Site Duarte California 91010 United States Details
GSK Investigational Site Los Angeles California 90027 United States Details
GSK Investigational Site Los Angeles California 90048 United States Details
GSK Investigational Site San Francisco California 94118 United States Details
GSK Investigational Site Santa Barbara California 93105 United States Details
GSK Investigational Site Stanford California 94305-5317 United States Details
GSK Investigational Site New Haven Connecticut 06510 United States Details
GSK Investigational Site Tampa Florida 33612 United States Details
GSK Investigational Site West Palm Beach Florida 33401 United States Details
GSK Investigational Site Atlanta Georgia 30342 United States Details
GSK Investigational Site Chicago Illinois 60611 United States Details
GSK Investigational Site Chicago Illinois 60637 United States Details
GSK Investigational Site Indianapolis Indiana 46260 United States Details
GSK Investigational Site Indianapolis Indiana 54244 United States Details
GSK Investigational Site Covington Louisiana 70433 United States Details
GSK Investigational Site New Orleans Louisiana 70121 United States Details
GSK Investigational Site Baltimore Maryland 21202 United States Details
GSK Investigational Site Boston Massachusetts 02115 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Burlington Massachusetts 01805 United States Details
GSK Investigational Site Ann Arbor Michigan 48109 United States Details
GSK Investigational Site Minneapolis Minnesota 55455 United States Details
GSK Investigational Site Rochester Minnesota 55905 United States Details
GSK Investigational Site Springfield Missouri 65804 United States Details
GSK Investigational Site Hackensack New Jersey 07601 United States Details
GSK Investigational Site Morristown New Jersey 07962-1956 United States Details
GSK Investigational Site East Setauket New York 11733 United States Details
GSK Investigational Site Jamaica New York 11432 United States Details
GSK Investigational Site Lake Success New York 11042 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Durham North Carolina 27710 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Medford Oregon 97504-8342 United States Details
GSK Investigational Site Wynnewood Pennsylvania 19096 United States Details
GSK Investigational Site Providence Rhode Island 02905 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Austin Texas 78731 United States Details
GSK Investigational Site Dallas Texas 75390 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site The Woodlands Texas 77380 United States Details
GSK Investigational Site Tyler Texas 75702 United States Details
GSK Investigational Site Spokane Washington 99202 United States Details
GSK Investigational Site Tacoma Washington 98405 United States Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H1T 2M4 Canada Details
GSK Investigational Site Montreal Quebec H2L 4M1 Canada Details
GSK Investigational Site Montreal Quebec H3T 1E2 Canada Details
GSK Investigational Site Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site Sherbrooke Quebec J1H 5N4 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field